Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disappearing bile ducts: immunologic mechanisms.

J M Vierling1, C D Howell

  • 1Liver Transplantation Program, Cedars-Sinai Medical Center, Los Angeles.

Hospital Practice (Office Ed.)
|July 15, 1990
PubMed
Summary

Immunologic mechanisms drive bile duct destruction in primary biliary cirrhosis, graft-versus-host disease, and liver transplant rejection, potentially causing liver failure. Understanding these pathways may improve treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expert clinical management of autoimmune hepatitis in the real world.

Alimentary pharmacology & therapeutics·2016
Same author

Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy.

Digestive diseases and sciences·2016
Same author

Grazoprevir plus peginterferon and ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infection: a randomized trial.

Journal of viral hepatitis·2015
Same author

Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II).

Alimentary pharmacology & therapeutics·2015
Same author

Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio.

Molecular genetics and metabolism·2013
Same author

End-stage renal disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infection.

Journal of viral hepatitis·2012

Area of Science:

  • Hepatology
  • Immunology
  • Transplantation

Background:

  • Intrahepatic bile duct destruction is a common pathway in several liver diseases.
  • Primary biliary cirrhosis, chronic graft-versus-host disease, and chronic liver transplant rejection share immunologic mechanisms leading to bile duct damage.
  • This damage can progress to liver failure if not effectively managed.

Purpose of the Study:

  • To review recent findings on the immunologic mechanisms causing intrahepatic bile duct destruction.
  • To discuss clinically relevant concepts related to these autoimmune liver conditions.
  • To highlight potential therapeutic targets based on a better understanding of disease pathogenesis.

Main Methods:

  • Review of recent scientific literature.
  • Synthesis of current knowledge on immunologic pathways in liver diseases.
  • Discussion of clinical implications and therapeutic strategies.

Main Results:

  • Immunologic responses are central to bile duct injury in the studied conditions.
  • Shared mechanisms underscore the interconnectedness of these diseases.
  • Understanding these pathways offers opportunities for targeted therapies.

Conclusions:

  • Targeting specific immunologic mechanisms holds promise for treating primary biliary cirrhosis, chronic graft-versus-host disease, and chronic liver transplant rejection.
  • Further research into these pathways can lead to novel therapeutic interventions.
  • Improved understanding of immunopathogenesis is crucial for preventing liver failure in these conditions.

Related Experiment Videos